In bladder cancer studies, gallic acid has been shown to modulate cell proliferation via the PI3K/AKT and MAPK/ERK pathways, as well as inhibit bladder cancer cell invasion and migration through regulation of p-AKT/MMP2 signaling (46). The gene discussed is AKT1; the disease is urinary bladder carcinoma.